Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ADMA BIOLOGICS, INC. (ADMA)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 77.1% | 98.6% | 145.2% | 134.6% | 248.4% | 128.1% | 59.7% | 60.1% |
| Gross profit | 22.9% | 1.4% | -45.2% | -34.6% | -148.4% | -28.1% | 40.3% | 39.9% |
| Selling, general and administrative | 34.0% | 53.0% | 83.0% | | | | | |
| Research and development | 2.3% | 4.5% | 14.0% | 8.0% | 23.1% | 24.5% | 72.1% | 97.7% |
| General and administrative | | | | 88.3% | 132.5% | 82.4% | 79.7% | 94.0% |
| Depreciation | 4.2% | 5.9% | 7.6% | 8.2% | 15.3% | 6.4% | 4.4% | 6.5% |
| EBITA | -25.1% | -71.2% | -152.1% | -138.3% | -350.0% | -163.6% | -162.6% | -216.1% |
| Amortization of intangibles | 0.5% | 0.9% | 1.7% | 2.9% | 5.0% | 5.4% | | |
| EBIT | -25.5% | -72.1% | -153.8% | -141.1% | -354.9% | -169.0% | -162.6% | -216.1% |
| Pre-tax income | -42.8% | -88.5% | -179.4% | -164.5% | -387.1% | -192.3% | -183.1% | -250.4% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -42.8% | -88.5% | -179.4% | -164.5% | -387.1% | -192.3% | -183.1% | -250.4% |
|